CGMP Manufacturing Facility
CGMP Manufacturing Facility

Owner

CRISPR Therapeutics

Location

Framingham, MA

CM Partner/Design

Commodore Builders, DPS
Crispr Therapeutics Rendering from DPS

Project Description

This project encompassed the 55,000 SF interior fit-out of existing shell space for a new cGMP biologics manufacturing facility, including lab spaces, MST labs, warehouse, utilities, and office space. Space includes new ISO 7 manufacturing suites with a modular cleanroom panel system as well as upstream/downstream process equipment.  Rendering courtesy of DPS Global Group.

The project received the 2022 Facility of the Year Award for Innovation from ISPE.  

  • This field is for validation purposes and should be left unchanged.